PP
AGIO icon

Paloma Partners’s Agios Pharmaceuticals AGIO Stock Holding History

Paloma Partners’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-41,200
Closed -$1.44M – 1597
2020
Q3 		$1.44M Buy
+41,200
New +$1.81M 0.04% 524
2019
Q2 		– Sell
-14,765
Closed -$996K – 1688
2019
Q1 		$996K Buy
+14,765
New +$860K 0.02% 732
2018
Q3 		– Sell
-7,375
Closed -$621K – 1502
2018
Q2 		$621K Sell
7,375
-3,825
-34% -$334K 0.01% 928
2018
Q1 		$916K Buy
+11,200
New +$866K 0.01% 1036
2017
Q4 		– Sell
-20,574
Closed -$1.37M – 1841
2017
Q3 		$1.37M Buy
+20,574
New +$1.24M 0.02% 976
2017
Q2 		– Sell
-20,977
Closed -$1.23M – 2130
2017
Q1 		$1.23M Buy
+20,977
New +$1.01M 0.01% 1111
2015
Q3 		– Sell
-28,750
Closed -$3.19M – 1582
2015
Q2 		$3.19M Buy
+28,750
New +$3.1M 0.06% 290

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return